These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 22835607)
21. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension. Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146 [TBL] [Abstract][Full Text] [Related]
22. Monocrotaline-induced pulmonary arterial hypertension is attenuated by TNF-α antagonists via the suppression of TNF-α expression and NF-κB pathway in rats. Wang Q; Zuo XR; Wang YY; Xie WP; Wang H; Zhang M Vascul Pharmacol; 2013 Jan; 58(1-2):71-7. PubMed ID: 22846229 [TBL] [Abstract][Full Text] [Related]
28. Formation of plexiform lesions in experimental severe pulmonary arterial hypertension. Abe K; Toba M; Alzoubi A; Ito M; Fagan KA; Cool CD; Voelkel NF; McMurtry IF; Oka M Circulation; 2010 Jun; 121(25):2747-54. PubMed ID: 20547927 [TBL] [Abstract][Full Text] [Related]
29. Coronary neovascularization of embryonic rat hearts cultured in oculo is independent of thyroid hormones. Rongish BJ; Torry RJ; Tomanek RJ Am J Physiol; 1995 Feb; 268(2 Pt 2):H811-6. PubMed ID: 7532375 [TBL] [Abstract][Full Text] [Related]
30. Pulmonary arterial hypertension and thyroid disease. Silva DR; Gazzana MB; John AB; Siqueira DR; Maia AL; Barreto SS J Bras Pneumol; 2009 Feb; 35(2):179-85. PubMed ID: 19287922 [TBL] [Abstract][Full Text] [Related]
31. Severe pulmonary hypertension: The role of metabolic and endocrine disorders. Bogaard HJ; Al Husseini A; Farkas L; Farkas D; Gomez-Arroyo J; Abbate A; Voelkel NF Pulm Circ; 2012; 2(2):148-54. PubMed ID: 22837855 [TBL] [Abstract][Full Text] [Related]
32. CrossTalk proposal: The mouse SuHx model is a good model of pulmonary arterial hypertension. Penumatsa KC; Warburton RR; Hill NS; Fanburg BL J Physiol; 2019 Feb; 597(4):975-977. PubMed ID: 30499212 [No Abstract] [Full Text] [Related]
33. CrossTalk opposing view: The mouse SuHx model is not a good model of pulmonary arterial hypertension. Vitali SH J Physiol; 2019 Feb; 597(4):979-981. PubMed ID: 30499185 [No Abstract] [Full Text] [Related]
34. New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis. Nicolls MR; Mizuno S; Taraseviciene-Stewart L; Farkas L; Drake JI; Al Husseini A; Gomez-Arroyo JG; Voelkel NF; Bogaard HJ Pulm Circ; 2012 Oct; 2(4):434-42. PubMed ID: 23372927 [TBL] [Abstract][Full Text] [Related]
35. Three-dimensional micro computed tomography analysis of the lung vasculature and differential adipose proteomics in the Sugen/hypoxia rat model of pulmonary arterial hypertension. Shields KJ; Verdelis K; Passineau MJ; Faight EM; Zourelias L; Wu C; Chong R; Benza RL Pulm Circ; 2016 Dec; 6(4):586-596. PubMed ID: 28090302 [TBL] [Abstract][Full Text] [Related]
36. Transpulmonary amino acid metabolism in the sugen hypoxia model of pulmonary hypertension. Philip N; Pi H; Gadkari M; Yun X; Huetsch J; Zhang C; Harlan R; Roux A; Graham D; Shimoda L; Le A; Visovatti S; Leary PJ; Gharib SA; Simpson C; Santhanam L; Steppan J; Suresh K Pulm Circ; 2023 Jan; 13(1):e12205. PubMed ID: 36873460 [TBL] [Abstract][Full Text] [Related]
37. Hepatoma-derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival. Yang J; Ambade AS; Nies M; Griffiths M; Damico R; Vaidya D; Brandal S; Pauciulo MW; Lutz KA; Coleman AW; Nichols WC; Austin ED; Ivy D; Hassoun PM; Everett AD Pulm Circ; 2022 Jan; 12(1):e12007. PubMed ID: 35506100 [TBL] [Abstract][Full Text] [Related]